Generation and partial characterization of an eosinophil chemotactic cytokine produced by sensitized equine mononuclear cells stimulated with Strongylus vulgaris antigen.

This study examines a cytokine that attracts eosinophils, produced when blood cells from ponies who have been sensitized to Strongylus vulgaris (a type of parasitic worm) interact with the worm’s antigen. The researchers found that the concentration of this cytokine increased with the amount of antigen and blood cells but was not affected by the amount of serum. This cytokine could contribute to increased levels of eosinophils found in the blood and tissues of ponies infected with S. vulgaris.

Research Methodology

• The researchers focused on eosinophil chemotactic activity (ECA), which is the process of attracting eosinophils (a type of disease-fighting white blood cell) to an area of the body.
• Peripheral blood mononuclear cells (PBMC) from ponies sensitized or immunized against the S. vulgaris parasite were stimulated. The supernatants (fluid that remains after cells settle) from these PBMCs were tested for ECA using a filter system in blind well chambers.

Research Findings

• The researchers found that these supernatants were chemotactic for eosinophils, or attracted eosinophils, but did not attract neutrophils, another type of white blood cell.
• It was found that ECA depended on both antigen and PBMC concentrations, though it was independent of serum concentrations.
• Partial characterization of the eosinophil chemotactic cytokine showed it to be nondialyzable, with a molecular weight exceeding 8000, and sensitive to heating, trypsin, and sodium metaperiodate treatments. This suggests that the cytokine is a protein with some essential carbohydrate parts.

Implications of the Research

• So, this cytokine led to an increase in the density of eosinophils—bluntly, it recruited more eosinophils. Consequently, it might be involved in the higher levels of eosinophils found in blood and tissues of ponies with an S. vulgaris infection.
• Understanding more about this cytokine and how it operates could potentially lead to new approaches to managing or treating equine parasites like S. vulgaris in the future.